Nathan J. Dowden, President & COO at Entrada Therapeutics, Inc. (TRDA), sold 30,020 shares at $13.02 ($392K) on 2026-03-09, disclosed to the SEC on 2026-03-11.
Seasonal sale ($392k) by President & COO — this insider has traded TRDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.02 | 3,116 | $41K | 10.4% |
| 2 | $13.02 | 3,116 | $41K | 10.4% |
| 3 | $13.05 | 11,894 | $155K | 39.6% |
| 4 | $13.05 | 11,894 | $155K | 39.6% |
| Total | $13.04 avg | 30,020 | $392K | 100% |
| Filing → |
| TRDA | SELL | 2024-09-10 | $35K | — | Filing → |
| TRDA | SELL | 2024-08-20 | $873K | — | Filing → |
| TRDA | SELL | 2024-03-08 | $22K | — | Filing → |